08-Nov-2022
Download PDF
Aurobindo Pharma
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the schedule of Earnings Call to be held on November 14 2022 at 8:30 AM (IST) on Unaudited Financial Results of the Company for the second quarter and half year ended September 30 2022.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
